In the quest to address infertility, Cornell researchers have developed a groundbreaking device that could simplify and automate oocyte cumulus removal, a critical step in assisted reproductive technologies.
DENVER, Sept. 4, 2025 /PRNewswire/ — Ultrasound AI™, Inc., a pioneer in artificial intelligence for medical imaging, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,369,883, “Artificial Intelligence System for Determining Clinical Values through Medical Imaging.” The patent protects the company’s proprietary system for determining current or future clinical or laboratory values directly from non-invasive medical images such as ultrasound.
A Ph.D. student at the University of Bristol has developed a convenient and cost-effective wearable patch to measure subtle temperature changes across the breast, which could in future be used to detect potential abnormalities and cancerous tumors.
Using a nasal mask instead of a traditional face mask to support very premature babies at birth can significantly reduce the need for rescue breathing and escalation of care, a world-first trial led by researchers at Monash University’s School of Clinical Sciences at Monash Health, in collaboration with Hudson Institute of Medical Research and Monash Children’s Hospital (Monash Health), has shown.
A genetic test of cord blood at birth may hold the key to predicting a child’s future risk of developing type 2 diabetes, according to exciting new research from Australia and Hong Kong.
Researchers from Kumamoto University have identified a distinctive CT imaging pattern that can predict which women experiencing severe postpartum hemorrhage (PPH) are most likely to need life-saving interventions.
A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection rates.
RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2025 /PRNewswire/ — Calidar, Inc., an innovative start-up in precision diagnostic imaging, today announced the successful imaging of the first patient with its 4D Mammography system.
Ovarian cancer is the leading cause of death among women with gynecological cancers. The current medical playbook—surgery followed by chemotherapy—initially shows promise.
The introduction of the test is underpinned by data from the blinded, prospective EXPAND study, which began in 2023.